Palisade Capital Management LLC Novo Nordisk A S Transaction History

Palisade Capital Management LLC

$3.26 Billion
Q1 2024

A detailed history of Palisade Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Palisade Capital Management LLC holds 199,431 shares of NVO stock, worth $28 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

199,431

Previous 236,420 15.65%

Holding current value

$28 Million

Previous $24.5 Million 4.7%

% of portfolio

0.78%

Previous 0.76%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $3.78 Million - $5.03 Million	-36,989 Reduced 15.65%	199,431 $25.6 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $477,172 - $573,226	-5,436 Reduced 2.25%	236,420 $24.5 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $11.9 Million - $26.2 Million	131,084 Added 118.34%	241,856 $22 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $3.22 Million - $3.56 Million	20,630 Added 22.89%	110,772 $17.9 Million
Q1 2023 May 08, 2023	SELL	$132.34 - $159.14 $207,112 - $249,054	-1,565 Reduced 1.71%	90,142 $14.3 Million

Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $30,457 - $40,193	-297 Reduced 0.32%	91,707 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $203,327 - $249,528	2,134 Added 2.37%	92,004 $9.17 Million
Q2 2022 Aug 10, 2022	BUY	$103.24 - $121.81 $40,366 - $47,627	391 Added 0.44%	89,870 $10 Million
Q1 2022 May 09, 2022	BUY	$93.1 - $112.54 $24,857 - $30,048	267 Added 0.3%	89,479 $9.94 Million
Q4 2021 Feb 10, 2022	BUY	$95.88 - $117.08 $9,588 - $11,708	100 Added 0.11%	89,212 $9.99 Million
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $86,266 - $108,069	-1,275 Reduced 1.41%	89,112 $7.47 Million
Q4 2020 Feb 11, 2021	BUY	$63.89 - $73.8 $19,933 - $23,025	312 Added 0.35%	90,387 $6.31 Million
Q2 2020 Aug 06, 2020	SELL	$58.54 - $67.94 $17,562 - $20,382	-300 Reduced 0.33%	90,075 $5.9 Million
Q3 2019 Nov 06, 2019	SELL	$47.54 - $53.43 $9,508 - $10,686	-200 Reduced 0.22%	90,375 $4.67 Million
Q2 2019 Aug 06, 2019	SELL	$46.79 - $52.47 $255,005 - $285,961	-5,450 Reduced 5.68%	90,575 $4.62 Million
Q1 2019 May 13, 2019	SELL	$46.36 - $52.63 $9,689 - $10,999	-209 Reduced 0.22%	96,025 $5.02 Million
Q4 2018 Feb 12, 2019	SELL	$41.54 - $47.25 $365,178 - $415,374	-8,791 Reduced 8.37%	96,234 $4.43 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $7,014 - $7,686	-150 Reduced 0.14%	105,025 $4.95 Million
Q2 2018 Aug 13, 2018	SELL	$44.29 - $50.42 $44,290 - $50,420	-1,000 Reduced 0.94%	105,175 $4.85 Million
Q4 2017 Feb 09, 2018	SELL	$47.53 - $53.73 $23,765 - $26,865	-500 Reduced 0.47%	106,175 $5.7 Million
Q3 2017 Oct 31, 2017	BUY	$41.15 - $49.22 $4.39 Million - $5.25 Million	106,675	106,675 $5.14 Million

Others Institutions Holding NVO

# of Institutions

1,864

Shares Held

310M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $317B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.

Account

Palisade Capital Management LLC Novo Nordisk A S Transaction History